- Home
- FBRX vs AMC Comparison
FBRX vs AMC Comparison
Compare FBRX & AMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FBRX | AMC |
|---|---|---|
| Founded | N/A | 1920 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 899.4M | 993.9M |
| IPO Year | 2017 | 2007 |
Fundamental Metrics
Financial Performance| Metric | FBRX | AMC |
|---|---|---|
| Price | $76.52 | $2.71 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 4 |
| Target Price | ★ $67.00 | $2.03 |
| AVG Volume (30 Days) | 1.9M | ★ 50.8M |
| Earning Date | 05-14-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.30 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $36,000.00 | ★ $4,848,900,000.00 |
| Revenue This Year | N/A | $11.41 |
| Revenue Next Year | N/A | $5.18 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 4.57 |
| 52 Week Low | $9.25 | $0.93 |
| 52 Week High | $76.68 | $3.26 |
Technical Indicators
Market Signals| Indicator | FBRX | AMC |
|---|---|---|
| Relative Strength Index (RSI) | 85.36 | 67.35 |
| Support Level | $24.72 | $1.66 |
| Resistance Level | N/A | $2.96 |
| Average True Range (ATR) | 4.60 | 0.21 |
| MACD | 3.29 | 0.07 |
| Stochastic Oscillator | 99.54 | 91.75 |
Price Performance
Historical ComparisonAbout FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
About AMC AMC Entertainment Holdings Inc.
AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. The company owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.